Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Clinical Trials > Combination Bosentan/Sildenafil Versus Sildenafil Monotherapy in Patients with Pulmonary Arterial Hypertension
Jumbo Large Regular Text:
Print
Clinical Trials

Combination Bosentan/Sildenafil Versus Sildenafil Monotherapy in Patients with Pulmonary Arterial Hypertension

Related Content

Health Articles

  • Understanding Clinical Trials: A participants' guide

In This Section

Related Clinical Trials

  • Pulmonology and Respiratory Medicine

Share

This trial examines the effects of combination of bosentan and sildenafil versus sildenafil monotherapy on morbidity and mortality in symptomatic patients with pulmonary arterial hypertension.

For more information, contact Melissa Willis, RN, at 919-684-6237.


(REF# 8325)
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Feb. 22, 2012
Published: Feb. 22, 2012
URL: http://www.dukehealth.org/clinicaltrials/combination-bosentan-sildenafil-versus-sildenfail-monotherapy-in-patients-with-pah